NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation

Etay Ziv,Yiru Zhang,Luke Kelly,Ines Nikolovski,F. Edward Boas,Joseph P. Erinjeri,Liqun Cai,Elena N. Petre,Lynn A. Brody,Anne M. Covey,George I. Getrajdman,James J. Harding,Constantinos T. Sofocleous,Ghassan K. Abou-Alfa,Stephen B. Solomon,Karen T. Brown,Hooman Yarmohammadi

NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation

2020

Etay Ziv
Yiru Zhang
Luke Kelly
Ines Nikolovski
F. Edward Boas
Joseph P. Erinjeri
Liqun Cai
Elena N. Petre
Lynn A. Brody
Anne M. Covey
George I. Getrajdman
James J. Harding
Constantinos T. Sofocleous
Ghassan K. Abou-Alfa
Stephen B. Solomon
Karen T. Brown
Hooman Yarmohammadi

Hepatocellular carcinomas with nuclear factor E2–related factor 2 (NRF2) mutation had rapid progression after transarterial embolization and showed resistance to ischemia, but also became more sens...

Keywords:

Medicine
Cohort study
Hepatocellular carcinoma
Ischemia
Gastroenterology
Internal medicine
Transarterial embolization

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations